Real-time context
Upgrades, downgrades, initiations, and price-target changes.
Rating Change Wells Fargo analysts reiterated a Overweight rating on EPAM Systems, Inc. (NYSE:EPAM) on July 10, 2026. Market Context EPAM Systems, Inc.
Read moreRating Change Citigroup analysts reiterated a Buy rating on Hasbro, Inc. (NASDAQ:HAS) on July 10, 2026. Market Context Hasbro, Inc.
Read moreRating Change Truist Securities analysts reiterated a Hold rating on Booz Allen Hamilton Holding Corporation (NYSE:BAH) on July 10, 2026. Market Context Booz Allen Hamilton…
Read moreRating Change Evercore ISI Group analysts reiterated a In-Line rating on Invesco Ltd. (NYSE:IVZ) on July 10, 2026. Market Context Invesco Ltd.
Read moreRating Change RBC Capital analysts reiterated a Outperform rating on Ally Financial Inc. (NYSE:ALLY) on July 10, 2026. Market Context Ally Financial Inc.
Read moreRating Change Evercore ISI Group analysts reiterated a Underperform rating on Franklin Resources, Inc. (NYSE:BEN) on July 10, 2026. Market Context Franklin Resources, Inc.
Read moreRating Change Truist Securities analysts reiterated a Hold rating on First Horizon Corporation (NYSE:FHN) on July 10, 2026. Market Context First Horizon Corporation operates in…
Read moreRating Change Evercore ISI Group analysts reiterated a In-Line rating on RenaissanceRe Holdings Ltd. (NYSE:RNR) on July 10, 2026. Market Context RenaissanceRe Holdings Ltd.
Read moreRating Change Canaccord Genuity analysts reiterated a Buy rating on AeroVironment, Inc. (NASDAQ:AVAV) on July 10, 2026. Market Context AeroVironment, Inc.
Read moreRating Change Citizens analysts reiterated a Market Outperform rating on AeroVironment, Inc. (NASDAQ:AVAV) on July 10, 2026. Market Context AeroVironment, Inc.
Read moreRating Change Citigroup analysts reiterated a Buy rating on Ionis Pharmaceuticals, Inc. (NASDAQ:IONS) on July 10, 2026. Market Context Ionis Pharmaceuticals, Inc.
Read moreRating Change Canaccord Genuity analysts reiterated a Buy rating on Ionis Pharmaceuticals, Inc. (NASDAQ:IONS) on July 10, 2026. Market Context Ionis Pharmaceuticals, Inc.
Read moreRating Change Barclays analysts reiterated a Overweight rating on Ionis Pharmaceuticals, Inc. (NASDAQ:IONS) on July 10, 2026. Market Context Ionis Pharmaceuticals, Inc.
Read moreRating Change Morgan Stanley analysts reiterated a Overweight rating on Ionis Pharmaceuticals, Inc. (NASDAQ:IONS) on July 10, 2026. Market Context Ionis Pharmaceuticals, Inc.
Read moreRating Change HC Wainwright & Co. analysts reiterated a Buy rating on Ionis Pharmaceuticals, Inc. (NASDAQ:IONS) on July 10, 2026.
Read moreRating Change Keefe, Bruyette & Woods analysts reiterated a Outperform rating on Houlihan Lokey, Inc. (NYSE:HLI) on July 10, 2026. Market Context Houlihan Lokey, Inc.
Read moreRating Change Jefferies analysts reiterated a Hold rating on ResMed Inc. (NYSE:RMD) on July 10, 2026. Market Context ResMed Inc.
Read moreRating Change Citigroup analysts reiterated a Neutral rating on Fiserv, Inc. (NASDAQ:FISV) on July 10, 2026. Market Context Fiserv, Inc.
Read moreRating Change Evercore ISI Group analysts reiterated a In-Line rating on The Hartford Insurance Group, Inc. (NYSE:HIG) on July 10, 2026. Market Context The Hartford Insurance…
Read moreRating Change Baird analysts reiterated a Neutral rating on Cognizant Technology Solutions Corporation (NASDAQ:CTSH) on July 10, 2026. Market Context Cognizant Technology…
Read more
